Cullinan Therapeutics (CGEM) Reports a Six-Month PFS Gain. Can it Justify Higher Toxicity?
Cullinan Therapeutics, Inc.
Cullinan Therapeutics Inc. (CGEM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 800,961 | $12,294,750 | +2126% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.40 | 165,667 | $1,391,685.63 | 8,963,500 | 2025-10-28 | Filing | |
| $7.84 | 32,217 | $252,565.17 | 8,797,833 | 2025-10-17 | Filing | |
| $8.86 | 150,000 | $1,328,250.00 | 8,765,616 | 2025-10-16 | Filing | |
| $7.94 | 51,500 | $409,049.05 | 8,615,616 | 2025-10-15 | Filing | |
| $7.59 | 15,032 | $114,047.78 | 8,564,116 | 2025-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.36 | 4,000 | $49,440.00 | 158,649 | 2026-11-05 | Filing | |
| $21.57 | 8,000 | $172,560.00 | 158,844 | 2026-09-08 | Filing | |
| $20.26 | 30,000 | $607,800.00 | 162,844 | 2026-08-13 | Filing | |
| $17.82 | 8,000 | $142,560.00 | 162,844 | 2026-07-06 | Filing | |
| $15.58 | 200 | $3,116.00 | 166,844 | 2026-05-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,448,600 | $22,240,987 | 0% | |
| 2. | 1,084,765 | $16,650,457 | 0% | |
| 3. | 377,837 | $5,799,798 | 0% | |
| 4. | 177,595 | $2,726,082 | 0% | |
| 5. | 173,387 | $2,661,486 | 0% |
News See All
Cullinan Therapeutics (CGEM) Jumps on Promising Phase 1 Data for CLN-049 in AML, Showing Strong Response Rates
Cullinan Therapeutics Inc. (NASDAQ:CGEM) is one of the stocks that will double in 2026.
20 Stocks That Will Double in 2026
On December 8, Kevin Mahn of Hennion & Walsh appeared on CNBC's 'Closing Bell Overtime' to discuss the potential for another bullish year, but with more volatility.
Cullinan Therapeutics to Present Updated Zipalertinib Data at IASLC 2025 World Conference on Lung Cancer
Cullinan Therapeutics Inc. (NASDAQ:CGEM) is one of the stocks under $10 to buy now. On July 22, Taiho Oncology Inc.
10 Stocks Under $10 to Buy Now
Earlier on July 1, Peter Kraus, Aperture Investors chairman and CEO, joined 'Squawk Box' on CNBC to suggest that the small and mid-cap area is a place for significant growth.
13 Best Booming Stocks to Buy Right Now
In this article, we will take a detailed look at the 13 Best Booming Stocks to Buy Right Now.
12 Cheap Healthcare Stocks to Buy in 2023
In this piece, we will take a look at the twelve cheap healthcare stocks to buy in 2023.
12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued pharma stocks to buy according to hedge funds.
11 Cheap Value Stocks to Buy According to Seth Klarman
In this article, we discuss the 11 cheap value stocks to buy according to Seth Klarman.
Hedge Fund Resource Center